Transcriptomic Profiling of Thyroid Eye Disease Orbital Fibroblasts Identifies Sorafenib as a Novel Therapeutic
Kyle Yuan, Phillip Truong, Charkira Patrick, Emma R. Ushchak, Elisa Roztocil, Steven E. Feldon, Collynn F. Woeller
This study identifies sorafenib as a potential therapeutic for thyroid eye disease by analyzing transcriptomic changes in orbital fibroblasts and validating its effects on key pathways.
Frontiers in Endocrinology · Aug 19, 2026Peer-reviewedMolecular Biology